The 16th European AIDS Conference, organised by the European AIDS Clinical Society (EACS), took place in Milan, Italy, from 25 to 27 October 2017.

Conference highlights

Transmission and prevention

HIV diagnoses in English gay men have been falling since 2014.

Conference bulletins

Catch up on EACS 2017 news with our summary bulletins. Available in English, French, Italian, Russian, Portuguese and Spanish.


Survey of dating app users finds that PrEP usage has not increased in Europe in the last year.

HIV testing services

How a London clinic reduced new HIV infections by 90% and why more European cities can do the same.

PEP and PrEP

High HIV incidence from non-primary partners and low PEP and PREP use seen in PARTNER study.

Treatment-experienced people

Fostemsavir controls viral load in half of people with highly drug-resistant HIV.

Hepatitis C treatment

Hepatitis C halved in Spanish people living with HIV in one year due to treatment.

Treatment guidelines

New EACS treatment guidelines.

Hepatitis C reinfection

High rate of hepatitis C reinfection in German men who have sex with men.

aidsmap news from EACS 2017

← First1Next →

Editors' picks from other sources

News bulletins

Sign up for our email bulletins

Find out more and sign up to the full range of aidsmap email bulletins >

Official conference website

Find out more about the conference on the official conference website.

Visit the conference website >

aidsmap news apps

Keep up to date with the latest HIV news using the free aidsmap news iPhone and android apps.

Download the app >

NAM's news coverage of the 16th European AIDS Conference has been supported by the European AIDS Clinical Society (EACS), and grants from Gilead Sciences Europe Ltd. and Merck Sharp & Dohme, Corp., a subsidiary of Merck & Co. Inc. NAM's wider conference news reporting services have been supported by Janssen and ViiV Healthcare.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.